Ballentine Partners’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,121
Closed -$102K 913
2024
Q4
$102K Buy
+31,121
New +$102K ﹤0.01% 843